NMM

(2S)-2-amino-5-[(N-methylcarbamimidoyl)amino]pentanoic acid

Find entries where: NMM

is present as a standalone ligand in 4 entries

is present in a polymer sequence 29 entries

Find related ligands:

Similar Ligands (Stereospecific)

Similar Ligands (including Stereoisomers)

Similar Ligands (Quick Screen)

Similar Ligands (Substructure Stereospecific)

Similar Ligands (Substructure including Stereoisomers)

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2S)-2-amino-5-[(N-methylcarbamimidoyl)amino]pentanoic acid
Synonyms	L-NMMA
Identifiers	(2S)-2-amino-5-[(N-methylcarbamimidoyl)amino]pentanoic acid
Formula	C₇ H₁₆ N₄ O₂
Molecular Weight	188.228
Type	L-PEPTIDE LINKING
Isomeric SMILES	[H]/N=C(/NC)\NCCC[C@@H](C(=O)O)N
InChI	InChI=1S/C7H16N4O2/c1-10-7(9)11-4-2-3-5(8)6(12)13/h5H,2-4,8H2,1H3,(H,12,13)(H3,9,10,11)/t5-/m0/s1
InChIKey	NTNWOCRCBQPEKQ-YFKPBYRVSA-N

Chemical Details
Formal Charge	0
Atom Count	29
Chiral Atom Count	1
Bond Count	28
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB11815
Name	Tilarginine
Groups	approved investigational
Description	Tilarginine has been investigated for the basic science, treatment, and diagnostic of Obesity, Type 2 Diabetes, Ocular Physiology, and Regional Blood Flow.
Synonyms	Targinine L-NMMA N(G)-Monomethyl-L-arginine L-Ng-monomethyl Arginine Tilarginine NG-Monomethyl-L-arginine Tilarginine citrate N-Methylarginine L-Monomethylarginine N(G)-Methylarginine omega-N-Monomethylarginine N5-(Methylamidino)-L-ornithine N-Monomethyl-L-arginine Tilarginine acetate Tilarginine hydrochloride omega-N-Methylarginine
Categories	Amino Acids Amino Acids, Basic Amino Acids, Diamino Amino Acids, Peptides, and Proteins Arginine Enzyme Inhibitors Nitric Oxide Synthase, antagonists & inhibitors
CAS number	17035-90-4

Related Resource References

Resource Name	Reference
Pharos	CHEMBL256147
PubChem	132862, 46906075
ChEMBL	CHEMBL256147
ChEBI	CHEBI:60257, CHEBI:124959, CHEBI:28229

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.